The clinical potential of ex vivo lung perfusion

Expert Review of Respiratory Medicine

Volumn 6, Issue 1, 2012, Pages 27-35

  Cypel, Marcelo ^a   Keshavjee, Shaf ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ex vivo lung perfusion; Lung injury; Lung preservation; Lung repair; Regeneration

Indexed keywords

CYTOKINE;

BIOREACTOR; BODY TEMPERATURE; CELL THERAPY; EX VIVO LUNG PERFUSION; GENE THERAPY; GENE TRANSFER; HUMAN; LUNG CANCER; LUNG FUNCTION; LUNG METASTASIS; LUNG PERFUSION; LUNG REGENERATION; LUNG TRANSPLANTATION; ORGAN DONOR; ORGAN PRESERVATION; PROTEIN EXPRESSION; REGENERATION; REVIEW;

EID: 84856473544     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.11.93     Document Type: Review

References (80)

1. Ware LB, Wang Y, Fang X et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 360(9333), 619-620 (2002). (Pubitemid 35232198)
2. Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: The role of brain death in donor lung injury. Transplantation 75(12), 1928-1933 (2003). (Pubitemid 36793270)
3. de Perrot M, Liu M, Waddell T, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am. J. Respir. Cell Mol. Biol. 28(5), 616-625 (2003).
4. Aigner C, Winkler G, Jaksch P et al. Extended donor criteria for lung transplantation - a clinical reality. Eur. J. Cardiothorac. Surg. 27(5), 757-761 (2005). (Pubitemid 40585666)
5. Van Raemdonck D, Neyrinck A, Verleden GM et al. Lung donor selection and management. Proc. Am. Thorac. Soc. 6(1), 28-38 (2009).
6. Cypel M, Yeung JC, Keshavjee S. Novel approaches to expanding the lung donor pool: Donation after cardiac death and ex vivo conditioning. Clin. Chest Med. 32(2), 233-244 (2011).
7. De Oliveira NC, Osaki S, Maloney JD et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J. Thorac. Cardiovasc. Surg. 139(5), 1306-1315 (2010).
8. Cypel M, Sato M, Yildirim E et al. Initial experience with lung donation after cardiocirculatory death in Canada. J. Heart Lung Transplant. 28(8), 753-758 (2009).
9. Snell GI, Levvey BJ, Oto T et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am. J. Transplant. 8(6), 1282-1289 (2008). (Pubitemid 351763684)
10. Mason DP, Thuita L, Alster JM et al. Should lung transplantation be performed using donation after cardiac death? The United States experience. J. Thorac. Cardiovasc. Surg. 136(4), 1061-1066 (2008).
11. Aigner C, Mazhar S, Jaksch P et al. Lobar transplantation, split lung transplantation and peripheral segmental resection - reliable procedures for downsizing donor lungs. Eur. J. Cardiothorac. Surg. 25(2), 179-183 (2004). (Pubitemid 38125077)
12. Yamane M, Date H, Okazaki M, Toyooka S, Aoe M, Sano Y. Long-term improvement in pulmonary function after living donor lobar lung transplantation. J. Heart Lung Transplant. 26(7), 687-692 (2007). (Pubitemid 47001709)
13. Carrel A, Lindbergh CA. The culture of whole organs. Science 81(2112), 621-623 (1935).
14. Jirsch DW, Fisk RL, Couves CM. Ex vivo evaluation of stored lungs. Ann. Thorac. Surg. 10(2), 163-168 (1970).
15. Fisk RL, Symes JF, Aldridge LL, Couves CM. The pathophysiology and experimental therapy of acid pneumonitis in ex vivo lungs. Chest 57(4), 364-370 (1970).
16. Cushman DW, Wang FL, Fung WC et al. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Br. J. Clin. Pharmacol. 28(Suppl. 2), S115-S130; discussion S130-S131 (1989).
17. Kanekal S, Plopper C, Morin D, Buckpitt A. Metabolic activation and bronchiolar Clara cell necrosis from naphthalene in the isolated perfused mouse lung. J. Pharmacol. Exp. Ther. 252(1), 428-437 (1990). (Pubitemid 20067746)
18. Kaplan E, Diehl JT, Peterson MB et al. Extended ex vivo preservation of the heart and lungs. Effects of acellular oxygencarrying perfusates and indomethacin on the autoperfused working heart-lung preparation. J. Thorac. Cardiovasc. Surg. 100(5), 687-697; discussion 697-688 (1990).
19. Seeger W, Schneider U, Kreusler B et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 76(7), 1438-1444 (1990). (Pubitemid 20342763)
20. Townsley MI, Barman SA, Taylor AE. Pulmonary embolism: Emboli and fibrinolysis inhibition in isolated canine lungs. Am. J. Physiol. 258(3 Pt 2), H754-H758 (1990). (Pubitemid 20103207)
21. Wang LS, Yoshikawa K, Miyoshi S et al. The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J. Thorac. Cardiovasc. Surg. 98(3), 333-342 (1989). (Pubitemid 19224259)
22. Brasile L, Stubenitsky BM, Kootstra G. Solving the organ shortage: Potential strategies and the likelihood of success. ASAIO J. 48(3), 211-215 (2002). (Pubitemid 35006981)
23. Brasile L, Stubenitsky BM, Booster MH et al. Overcoming severe renal ischemia: The role of ex vivo warm perfusion. Transplantation 73(6), 897-901 (2002). (Pubitemid 34252351)
24. Brasile L, Buelow R, Stubenitsky BM, Kootstra G. Induction of heme oxygenase-1 in kidneys during ex vivo warm perfusion. Transplantation 76(8), 1145-1149 (2003). (Pubitemid 37339634)
25. Brasile L, Stubenitsky BM, Booster MH, Haisch C, Kootstra G. NOS: The underlying mechanism preserving vascular integrity and during ex vivo warm kidney perfusion. Am. J. Transplant. 3(6), 647-649 (2003).
26. Brasile L, Stubenitsky BM, Haisch CE, Kon M, Kootstra G. Repair of damaged organs in vitro. Am. J. Transplant. 5(2), 300-306 (2005). (Pubitemid 40179516)
27. Imber CJ, St Peter SD, Lopez de Cenarruzabeitia I et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 73(5), 701-709 (2002). (Pubitemid 34260564)
28. Steen. S, Liao Q, Wierup PN, Bolys R, Pierre L, Sjöberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann. Thorac. Surg. 76(1), 244-252 (2003). (Pubitemid 36819750)
29. Daemen JW, Kootstra G, Wijnen RM, Yin M, Heineman E. Nonheart-beating donors: The Maastricht experience. Clin. Transpl. 303-316 (1994).
30. Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 357, 825-829 (2001). (Pubitemid 32239366)
31. Meers CM, Tsagkaropoulos S, Wauters S et al. A model of ex vivo perfusion of porcine donor lungs injured by gastric aspiration: A step towards pretransplant reconditioning. J. Surg. Res. 170(1), e159-e167 (2011).
32. Egan TM, Haitchcock JA, Nicotra WA, Koukoulis G, Inokawa H, Sevala M. Ex vivo evaluation of human lungs for transplant suitability. Ann. Thorac. Surg. 81(4), 1205-1213 (2006).
33. Snell GI, Oto T, Levvey B et al. Evaluation of techniques for lung transplantation following donation after cardiac death. Ann. Thorac. Surg. 81(6), 2014-2019 (2006). (Pubitemid 43775541)
34. Neyrinck AP, Van De Wauewer C, Geudens N, Rega FR, Verleden GM, Wouters Comparative study of donor lung injury in heart-beating versus non-heart-beating donors. Eur. J. Cardiothorac. Surg. 30(4), 628-636 (2006). (Pubitemid 44332938)
35. Rega FR, Vanaudenaerde BM, Wuyts WA et al. IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J. Heart Lung Transplant. 24(1), 20-28 (2003). (Pubitemid 40093987)
36. Cypel M, Yeung JC, Hirayama S et al. Technique for prolonged normothermic ex vivo lung perfusion. J. Heart Lung Transplant. 27(12), 1319-1325 (2008).
37. Cypel M, Rubacha M, Yeung J et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am. J. Transplant. 9(10), 2262-2269 (2009).
38. Cypel M, Liu M, Rubacha M et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci. Transl. Med. 1(4), 1-9 (2009).
39. Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 357(9259), 825-829 (2001). (Pubitemid 32239366)
40. Ingemansson R, Eyjolfsson A, Mared L et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann. Thorac. Surg. 87(1), 255-260 (2009).
41. Lindstedt S, Hlebowicz J, Koul B et al. Comparative outcome of double lung transplantation using conventional donor lungs and non-acceptable donor lungs reconditioned ex vivo. Interact. Cardiovasc. Thorac. Surg. 12(2), 162-165 (2011).
42. Cypel M, Yeung JC, Liu M et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N. Engl. J. Med. 364(15), 1431-1440 (2011).
43. Christie JD, Sager JS, Kimmel SE et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 127(1), 161-165 (2005). (Pubitemid 41724571)
44. Yeung C, Koike T, Cypel M et al. Airway pressure and compliance in the evaluation of donor lung injury during protective ex vivo lung perfusion in a porcine brain death model. J. Heart Lung Transplant. 30(4), S143 (2011).
45. Orens JB, Boehler A, de Perrot M et al. A review of lung transplant donor acceptability criteria. J. Heart Lung Transplant. 22(11), 1183-1200 (2003). (Pubitemid 37324693)
46. Kaneda H, Waddell TK, de Perrot M et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am. J. Transplant. 6(3), 544-551 (2006). (Pubitemid 43382141)
47. Cypel M, Yildirim E, Boasquevisque C et al. Donor scoring does not predict early outcome. J. Heart Lung Transplant. 26(2 Suppl. 1), S212-S213 (2008).
48. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 24(10), 1454-1459 (2005). (Pubitemid 41396439)
49. de Perrot M, Bonser RS, Dark J et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: Donorrelated risk factors and markers. J. Heart Lung Transplant. 24(10), 1460-1467 (2005). (Pubitemid 41396440)
50. De Perrot M, Sekine Y, Fischer S et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am. J. Respir. Crit. Care Med. 165(2), 211-215 (2002). (Pubitemid 34084460)
51. Fisher AJ, Donnelly SC, Hirani N et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am. J. Respir. Crit. Care Med. 163(1), 259-265 (2001). (Pubitemid 32095278)
52. Anraku M, Cameron MJ, Waddell TK et al. Impact of Human Donor Lung Gene Expression Profiles on Survival after Lung Transplantation: A case-control study. Am. J. Transplant. 8(10), 2140-2148 (2008).
53. Kang CH, Anraku M, Cypel M et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: A functional pathway analysis. J. Heart Lung Transplant. 30(3), 289-298 (2011).
54. Ray M, Dharmarajan S, Freudenberg J, Zhang W, Patterson GA. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am. J. Transplant. 7(10), 2396-2405 (2007). (Pubitemid 47347845)
55. Das J, Kelley SO. Protein detection using arrayed microsensor chips: Tuning sensor footprint to achieve ultrasensitive readout of CA-125 in serum and whole blood. Anal. Chem. 83(4), 1167-1172 (2011).
56. Frank JA, Briot R, Lee JW, Ishizaka A, Uchida T, Matthay MA. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 293(1), 52-59 (2007).
57. Sakuma T, Gu X, Wang Z et al. Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Crit. Care Med. 34(3), 676-681 (2006).
58. Frank JA, Briot R, Lee JW, Ishizaka A, Uchida T, Matthay MA. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 293(1), L52-59 (2007). (Pubitemid 47080706)
59. Planes C, Blot-Chabaud M, Matthay MA, Couette S, Uchida T, Clerici C. Hypoxia and beta 2-agonists regulate cell surface expression of the epithelial sodium channel in native alveolar epithelial cells. J. Biol. Chem. 277(49), 47318-47324 (2002). (Pubitemid 36159245)
60. Oto T, Excell L, Griffiths AP, Levvey BJ, Snell GI. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J. Heart Lung Transplant. 27(1), 78-85 (2008).
61. Inci I, Zhai W, Arni S et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J. Heart Lung Transplant. 26(10), 1054-1060 (2007). (Pubitemid 47494662)
62. Karamanou DM, Perry J, Walden HR et al. The effect of ex-vivo perfusion on the microbiological profile of the donor lung. J. Heart Lung Transplant. 29(2 Suppl.), S88 (2010).
63. Inci I, Ampollini L, Arni S et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J. Heart Lung Transplant. 27(11), 1229-1236 (2008).
64. Hirayama S, Cypel M, Sato M et al. Activated protein C in ischemia-reperfusion injury after experimental lung transplantation. J. Heart Lung Transplant. 28(11), 1180-1184 (2009).
65. Nita I, Hollander C, Westin U, Janciauskiene SM. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir. Res. 6, 12 (2005).
66. Ishiyama T, Dharmarajan S, Hayama M, Moriya H, Grapperhaus K, Patterson GA. Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J. Thorac. Cardiovasc. Surg. 130(1), 194-201 (2005). (Pubitemid 40941690)
67. Fischer S, Liu M, MacLean AA et al. In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia- reperfusion injury and improves early posttransplant graft function in the rat. Hum. Gene Ther. 12(12), 1513-1526 (2001). (Pubitemid 34248287)
68. Martins S, de Perrot M, Imai Y et al. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther. 11(24), 1786-1796 (2004). (Pubitemid 40028540)
69. Zhao M, Fernandez LG, Doctor A et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia- reperfusion injury. Am. J. Physiol. Lung Cell Mol. Physiol. 291(5), L1018-L1026 (2006). (Pubitemid 44772064)
70. Ritter T, Kupiec-Weglinski JW. Gene therapy for the prevention of ischemia/reperfusion injury in organ transplantation. Curr. Gene Ther. 5(1), 101-109 (2005). (Pubitemid 40246743)
71. Cassivi SD, Cardella JA, Fischer S, Liu M, Slutsky AS, Keshavjee S. Transtracheal gene transfection of donor lungs prior to organ procurement increases transgene levels at reperfusion and following transplantation. J. Heart Lung Transplant. 18(12), 1181-1188 (1999).
72. Chapelier A, Danel C, Mazmanian M et al. Gene therapy in lung transplantation: Feasibility of ex vivo adenovirus-mediated gene transfer to the graft. Hum. Gene Ther. 7(15), 1837-1845 (1996). (Pubitemid 26364592)
73. Pellegrini C, O'Brien T, Jeppsson A et al. Influence of temperature on adenovirusmediated gene transfer. Eur. J. Cardiothorac. Surg. 13(5), 599-603 (1998). (Pubitemid 28273355)
74. Yeung JC, Wagnetz D, Koike T, Rubacha M, Cypel M, Keshavjee S. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation. J. Heart Lung Transplant. 29(2 Suppl.), S95 (2010).
75. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Natl Acad. Sci. USA 106(38), 16357-16362 (2009).
76. Ott HC, Clippinger B, Conrad C et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 16(8), 927-933 (2010).
77. Petersen TH, Calle EA, Zhao L et al. Tissue-engineered lungs for in vivo implantation. Science 329(5991), 538-541 (2010).
78. Grootenboers MJ, Heeren J, van Putte BP et al. Isolated lung perfusion for pulmonary metastases, a review and work in progress. Perfusion 21(5), 267-276 (2006).
79. Van Schil PE, Hendriks JM, van Putte BP et al. Isolated lung perfusion and related techniques for the treatment of pulmonary metastases. Eur. J. Cardiothorac. Surg. 33(3), 487-496 (2008).
80. Den Hengst WA, Van Putte BP, Hendriks JM et al. Long-term survival of a Phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases. Eur. J. Cardiothorac. Surg. 38(5), 621-627 (2010).